Vacheva I. THE ANTI-INTERLEUKIN-31 ANTIBODY LOKIVETMAB AS A NEW ADDITIONAL OPTION FOR CANINE ATOPIC DERMATITIS MANAGEMENT. Tradit. Mod. Vet. Med. [Internet]. 2026 Apr. 18 [cited 2026 Apr. 24];11(1):49-54. Available from: https://scij-tmvm.com/index.php/pub/article/view/306